Reliable assessment of harmful alcohol consumption requires biomarkers that deliver accurate and comparable results across laboratories. This article reviews the importance of standardization and traceability in alcohol biomarker testing and explains why CDT-IFCC stands out as the only alcohol biomarker supported by an internationally recognized reference measurement system, ensuring confidence in clinical and forensic decision-making.
Knowledge & Science
Results
M. Jean Deenmamode, IFCC CDT Working group Chair, during this interview comes back on the definition of the excessive chronic alcohol consumption and its impact on the individuals and society.
Algorithm for congenital and acquired von Willebrand disease includes Hydragel vWF multimer analysis.
Evaluation of Sebia’s isoelectrofocusing kit for A1AT with HYDRASYS.
Following IFCC CDT Working group recommendation, Sebia designed the CDTI FCC test on the CAPILLARYS analysers.
The HYDRASHIFT portfolio include IVD test to mitigate interferences seen in immunofixation result for patient treated with isatuximab or daratumumab.